Apr 17, 2026
Eli Lilly (LLY) Stock Jumps 3% Following Strong Foundayo Clinical Data and Launch Metrics
Eli Lilly (LLY) stock climbs 3% after Foundayo's debut week prescriptions reach 1,390 and trial shows significant cardiovascular and mortality benefits.
The post Eli Lilly (LLY) Stock Jumps 3% Following Strong Foundayo Clinical Data and Launch Metrics appeared first on Blockonomi.
Source: Blockonomi →Related News
- 17 minutes ago
Zoetis (ZTS) Stock Plummets 20% Following Disappointing Q1 Results and Guidance...
- 23 minutes ago
Micron (MU) Stock Surges to Record High on $740 Price Target from Mizuho
- 30 minutes ago
Berkshire Hathaway (BRK.B) Stock: New Insider Purchase Signals Confidence Despit...
- 31 minutes ago
Kalshi Secures $1 Billion in Funding as Prediction Markets Explode on Wall Stree...
- 32 minutes ago
Planet Fitness (PLNT) Shares Crater 33% Following Disappointing 2026 Forecast Re...